Sequoia Financial Advisors LLC Takes Position in DaVita Inc. (NYSE:DVA)

Sequoia Financial Advisors LLC acquired a new stake in shares of DaVita Inc. (NYSE:DVA) during the 4th quarter, according to its most recent filing with the SEC. The institutional investor acquired 2,937 shares of the company’s stock, valued at approximately $308,000.

Other institutional investors have also recently modified their holdings of the company. Resources Management Corp CT ADV grew its position in DaVita by 5,900.0% during the 2nd quarter. Resources Management Corp CT ADV now owns 300 shares of the company’s stock worth $30,000 after acquiring an additional 295 shares during the last quarter. Parkside Financial Bank & Trust grew its position in DaVita by 88.6% during the 1st quarter. Parkside Financial Bank & Trust now owns 313 shares of the company’s stock worth $35,000 after acquiring an additional 147 shares during the last quarter. Harbor Investment Advisory LLC bought a new position in DaVita during the 3rd quarter worth approximately $34,000. Hanseatic Management Services Inc. bought a new position in DaVita during the 3rd quarter worth approximately $36,000. Finally, FinTrust Capital Advisors LLC grew its position in DaVita by 242.3% during the 3rd quarter. FinTrust Capital Advisors LLC now owns 712 shares of the company’s stock worth $67,000 after acquiring an additional 504 shares during the last quarter. 90.12% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

DVA has been the topic of several recent research reports. Barclays assumed coverage on DaVita in a research report on Wednesday, March 6th. They set an “equal weight” rating and a $133.00 price target on the stock. UBS Group lifted their price objective on DaVita from $113.00 to $134.00 and gave the stock a “buy” rating in a research report on Wednesday, February 14th. Truist Financial lifted their price objective on DaVita from $130.00 to $135.00 and gave the stock a “hold” rating in a research report on Tuesday, February 20th. StockNews.com lowered DaVita from a “strong-buy” rating to a “buy” rating in a research report on Tuesday. Finally, TheStreet upgraded DaVita from a “c+” rating to a “b-” rating in a research report on Wednesday, February 7th. Two investment analysts have rated the stock with a hold rating and two have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $118.50.

Insider Buying and Selling at DaVita

In other DaVita news, CEO Javier Rodriguez sold 67,603 shares of DaVita stock in a transaction on Monday, February 26th. The stock was sold at an average price of $126.11, for a total transaction of $8,525,414.33. Following the completion of the transaction, the chief executive officer now owns 488,697 shares in the company, valued at $61,629,578.67. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. In other DaVita news, CEO Javier Rodriguez sold 67,603 shares of DaVita stock in a transaction on Monday, February 26th. The stock was sold at an average price of $126.11, for a total transaction of $8,525,414.33. Following the completion of the transaction, the chief executive officer now owns 488,697 shares in the company, valued at $61,629,578.67. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, COO Michael David Staffieri sold 29,488 shares of DaVita stock in a transaction on Wednesday, February 21st. The shares were sold at an average price of $119.81, for a total value of $3,532,957.28. Following the transaction, the chief operating officer now owns 37,687 shares of the company’s stock, valued at approximately $4,515,279.47. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 134,540 shares of company stock worth $16,551,071. 1.40% of the stock is owned by insiders.

DaVita Trading Down 1.2 %

DVA opened at $126.11 on Friday. The stock has a market cap of $11.06 billion, a PE ratio of 17.04, a PEG ratio of 1.16 and a beta of 1.04. The company has a quick ratio of 1.13, a current ratio of 1.19 and a debt-to-equity ratio of 6.65. The business has a 50 day moving average of $130.32 and a 200-day moving average of $108.79. DaVita Inc. has a 52 week low of $71.51 and a 52 week high of $141.54.

DaVita (NYSE:DVA) last released its earnings results on Tuesday, February 13th. The company reported $1.87 EPS for the quarter, beating analysts’ consensus estimates of $1.53 by $0.34. The company had revenue of $3.15 billion during the quarter, compared to analysts’ expectations of $3.01 billion. DaVita had a return on equity of 64.42% and a net margin of 5.70%. The firm’s revenue for the quarter was up 7.8% compared to the same quarter last year. During the same quarter last year, the business posted $1.11 EPS. Equities research analysts predict that DaVita Inc. will post 9.23 earnings per share for the current fiscal year.

DaVita Company Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.